CIGB-228

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCIGB-228
Drug Alias NameCIGB-228
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionProtein E7 modulators
TargetsProtein E7
Therapy Area/IndicationsUterine Cervical NeoplasmsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCenter For Genetic Engineering And Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesCenter For Genetic Engineering And Biotechnology
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A